Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03824704
Title A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

ovary epithelial cancer

fallopian tube cancer

peritoneum cancer

Therapies

Nivolumab + Rucaparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.